A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B
Clinical trial NCT06452693 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06452693
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2026-09-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.